Trans Care: An Online Intervention to Reduce Symptoms of Gender Dysphoria
NCT ID: NCT05903911
Last Updated: 2025-05-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
312 participants
INTERVENTIONAL
2024-12-12
2025-05-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Trans Care: An Online Intervention to Reduce Symptoms of Gender Dysphoria
NCT05884307
Feasibility and Acceptability of Mindful Self-Compassion Among Transgender and Nonbinary Young Adults
NCT06409975
Reducing Transphobia Among Adolescents Through a Brief Video Intervention
NCT04969003
Transgender Post-reassignment Urogynecologic Measures and Perceptions
NCT03293771
Evaluation of the Variation in Quality of Life During Medical Transition for Transgender People.
NCT05273112
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Aim 1) Feasibility and acceptability analysis (FAA) \[represented by NCT05884307\]
* Aim 2) A pilot randomized controlled trial (RCT) of Trans Care's efficacy \[represented in this study record\]
Aim 2 is a RCT in which participants' scores of psychological wellbeing and coping strategies in the intervention vs waitlist control group will be analyzed. Additionally, participants who drop out of the RCT will be asked to complete measures at dropout to determine what dose size of Trans Care (i.e., how many modules) is necessary to have a significant change in mental well-being. Finally, waitlisted participants will be offered the intervention within one month of the completion of data collection.
Aim 2 Hypotheses:
* TNB Participants who received the Trans Care intervention will demonstrate improvement on quantitative measures of psychological well-being, GD symptoms, and coping strategies compared to waitlisted individuals.
* Changes will be maintained at 3 months follow-up indicating that the Trans Care intervention has a sustained impact on improving TNB individuals' coping.
Aim 2 Endpoints:
The primary endpoint of Aim 2 will be to determine if participants who engaged the Trans Care intervention experienced psychological improvement in their mental health as a result of completing the intervention.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Trans Care Intervention
Trans Care Web App
an educational and interactive website designed to improve coping strategies of TNB individuals
Waitlist Control
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Trans Care Web App
an educational and interactive website designed to improve coping strategies of TNB individuals
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Experience gender dysphoria.
* Time available to commit to completing a 4-5-hour online intervention and 1-2 hours to complete follow up surveys
Exclusion Criteria
* individual does not identify as transgender, transsexual, nonbinary, and/or have a transgender history
* does not experience gender dysphoria
* is unable to commit to the time requirements of the study
* does not have access to an internet compatible device
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Wisconsin, Madison
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stephanie Budge, PhD, LP
Role: PRINCIPAL_INVESTIGATOR
University of Wisconsin, Madison
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Wisconsin
Madison, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lindley, L., & Budge, S. L. (2022). Development and validation of the Trans and Nonbinary Coping Measure (TNCM): A measure of trans and nonbinary specific ways of coping with gender-related stress. Psychology of Sexual Orientation and Gender Diversity. Advance online publication. https://doi.org/10.1037/sgd0000618
Related Links
Access external resources that provide additional context or updates about the study.
Public Record for Trans Care: An Online Intervention to Reduce Symptoms of Gender Dysphoria Feasibility and Acceptability Study
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UW Baldwin Endowment
Identifier Type: OTHER
Identifier Source: secondary_id
A171600
Identifier Type: OTHER
Identifier Source: secondary_id
Protocol Version 10/17/24
Identifier Type: OTHER
Identifier Source: secondary_id
2023-0644: RCT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.